Catecholamine-resistant hypotension following induction for spinal exploration

AANA Journal

Volumn 80, Issue 1, 2012, Pages 55-60

  Trotter, Jason ^a,b  

^a Sara Bush Lincoln Health Center   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Blood pressure regulation; Catecholamineresistant; Complications; Drug interactions; General anesthesia; Hypotension

Indexed keywords

ATENOLOL; ATORVASTATIN; CARBIDOPA; CATECHOLAMINE; CORTICOSTEROID; EPHEDRINE; FUROSEMIDE; IRBESARTAN; OMEPRAZOLE; PHENYLEPHRINE; SPIRONOLACTONE; VANCOMYCIN; VASOPRESSIN; ANESTHETIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST;

AGED; ARTICLE; BACKACHE; BLOOD PRESSURE; CASE REPORT; CYST; DRUG WITHDRAWAL; GENERAL ANESTHESIA; HUMAN; HYPOTENSION; INTERVERTEBRAL DISKECTOMY; MALE; PARESTHESIA; PARKINSON DISEASE; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME; SPINE SURGERY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; DRUG EFFECT; DRUG INTERACTION; DRUG RESISTANCE; HYPERTENSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPINE DISEASE;

AGED; ANESTHESIA, GENERAL; ANESTHETICS; ANGIOTENSIN RECEPTOR ANTAGONISTS; CATECHOLAMINES; DRUG INTERACTIONS; DRUG RESISTANCE; HUMANS; HYPERTENSION; HYPOTENSION; MALE; RENIN-ANGIOTENSIN SYSTEM; SPINAL DISEASES;

EID: 84860234537     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Critchley L. Hypotension, subarachnoid block and the elderly patient. Anaesthesia. 1996;51(12):1139-1143.
2. Davies IB. Chronic hypotension. J R Soc Med. 1982;75(8):577-580.
3. Behnia R, Molteni A, Igić R. Angiotensin-converting enzyme inhibitors: mechanism of action and implications in anesthesia practice. Curr Pharm Des. 2003;9(9):763-776.
4. Coriat P, Richer C. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology. 1994;81 (2):299-307.
5. Lange M, Van Aken H, Westphal M, Morelli A. Role of vasopressinergic V1 receptor agonists in the treatment of perioperative catecholamine-refractory arterial hypotension. Best Pract Res Clin Anaesthesiol. 2008;22(2):369-381.
6. Brabant S, Bertrand M, Eyraud D, Darmon P, Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg. 1999;89(6):1388-1392.
7. Oh Y, Lee J, Nam S, Shim J, Song J, Kwak Y. Effects of chronic angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass. Br J Anaesth. 2006;97(6):792-798.
8. Colson P, Ryckwaert F. Renin angiotensin system antagonists and anesthesia. Anesth Analg. 1999;89(5):1143-1155.
9. Atlas S. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 2007;13(8 suppl 8):9-20.
10. Treschan TA, Peters J. The vasopressin system: physiology and clinical strategies. Anesthesiology. 2006;105(3):599-612.
11. Izzo JL Jr, Taylor AA. The sympathetic nervous system and baroreflexes in hypertension and hypotension. Curr Hypertens Rep. 1999; 1(3):254-263.
12. Wheeler AD, Turchiano J, Tobias JD. A case of refractory intraoperative hypotension treated with vasopressin infusion. J Clin Anesth. 2008;20(2):139-142.
13. Comfere T, Sprung J, Kumar M, et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg. 2005;100(3):636-644.
14. Morelli A, Tritapepe L, Rocco M, et al. Terlipressin versus norepinephrine to counteract anesthesia-induced hypotension in patients treated with renin-angiotensin system inhibitors: effects on systemic and regional hemodynamics. Anesthesiology. 2005;102(1):12-19.
15. Carp H, Vadhera R, Jayaram A, Garvey D. Endogenous vasopressin and renin-angiotensin systems support blood pressure after epidural block in humans. Anesthesiology. 1994;80(5):1000-1007.
16. Boccara G, Ouattara A, Godet G, et al. Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors. Anesthesiology. 2003;98(6):1338-1344.
17. Eyraud D, Brabant S, Nathalie D, et al. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin angiotensin system. Anesth Analg. 1999;88(5):980-984.
18. Singer M. Arginine vasopressin vs terlipressin in the treatment of shock states. Best Pract Res Clin Anaesthesiol. 2008;22(2):359-368.
19. Delmas A, Leone M, Rousseau S, Albanese J, Martin C. Clinical review: vasopressin and terlipressin in septic shock states. Crit Care. 2005;9(2):212-222.
20. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 2005;45(1):9-14.
21. Green DE, Schulman DA. Obstructive sleep apnea and cardiovascular disease. Curr Treat Options Cardiovasc Med. 2010;12(4):342-354.